Yehuda Eliya - Dec 5, 2022 Form 4 Insider Report for Raphael Pharmaceutical Inc. (RAPH)

Role
Chief Financial Officer, Director
Signature
/s/ Yehuda Eliya
Stock symbol
RAPH
Transactions as of
Dec 5, 2022
Transactions value $
$0
Form type
4
Date filed
3/13/2023, 04:03 PM
Previous filing
Jan 19, 2022
Next filing
Mar 25, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RAPH Warrants to Purchase Common Stock Award $0 +202K $0.00 202K Dec 5, 2022 Common Stock 202K $1.12 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The warrants are exercisable immediately.